About us
In January 2023, WHO’s Director-General announced plans to establish a TB vaccine accelerator Council to facilitate the development, testing, authorization, and use of new TB vaccines, drawing on lessons learned from the response to the COVID-19 pandemic. The establishment meeting of the Council took place on 20 September 2023, on the occasion of the 78th session of the United Nations General Assembly, in the lead up to the Second United Nations High-level Meeting on TB.
The Council is anticipated to work in multiple ways. These include
- identifying needs for, and types of innovative sustainable financial solutions, as well as partnerships between the public, private and philanthropic sectors that can expedite the translation of science into TB vaccines, and ensure their equitable access once available;
- identifying market solutions to incentivize TB vaccine development, and to ensure that the R&D ecosystem is positioned to rapidly manufacture and distribute vaccines equitably and at scale, once they are available; and
- advocating with decision makers in the public, private, philanthropy and other relevant sectors to strengthen commitment and concerted action to develop and expand access to novel effective TB vaccines, including through political platforms such as the African Union, ASEAN, BRICS, G20, G7 and others.
Participation
The Council will have multiple platforms, the highest level being a Ministerial Board. Another high-level strategic body, a Principal Group will engage senior leadership from financing organizations, philanthropy, public health agencies, relevant partnerships and international agencies and representative of people affected by TB. The Members of the Ministerial Board and Principal Group will serve on a rotating basis, for a term of two years.
Other stakeholders, including research organizations, private sector, scientist, regulators, civil society, and others will be engaged through subsidiary bodies. For more information, see the "architecture of the Council".
Status
The TB vaccine accelerator council is a WHO initiative, an informal voluntary network to exchange views, share information, and enhance technical and political co-operation. It is not a distinct legal entity, and it derives its legal status from WHO. Thus, it shall be administered by WHO, which provides its Secretariat.
Members of the Ministerial Board
Dr Nísia Trindade Lima (Co-chair)
Minister of Health, Brazil
Dr Budi Gunadi Sadikin (Co-chair)
Minister of Health, Indonesia
Mr Aurélien Rousseau
Minister of Social Affairs and Health, France
Dr Susan Nakhumicha Wafula
Cabinet Secretary for Health, Kenya
Ms Dao Hong Lan
Minister of Health, Viet Nam
Dr Malik Mukhtar Ahmed Bharath
Coordinator to Prime Minister on Health, Pakistan
Dr Mathume Joseph Phaahla
Minister of Health, South Africa
Dr Teodoro J. Herbosa
Secretary of Health, Philippines
National Institutes of Health
National Institutes of Health, United States of America
Members of the Principal Group
Dr Akinwumi Adesina
President, African Development Bank Group
Dr Trevor Mundel
President of Global Health, Bill and Melinda Gates Foundation
Ms Nadia Calvino
President, European Investment Bank
Dr Juan Pablo Uribe
Global Director for Health, Nutrition & Population and the Global Financing Facility, World Bank
Dr Sania Nishtar
Chief Executive Officer, Gavi, the Vaccine Alliance
Mr Peter Sands
Executive Director, Global Fund
Dr Philippe Duneton
Executive Director, Unitaid
Dr John-Arne Røttingen
Chief Executive Officer, Wellcome Trust
Dr Lucica Ditiu
Executive Director, Stop TB Partnership
Mike Frick
Co-Director of Tuberculosis Project, Treatment Action Group
Events
All →